...
首页> 外文期刊>Stem cell research >Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction
【24h】

Inferior ectopic bone formation of mesenchymal stromal cells from adipose tissue compared to bone marrow: Rescue by chondrogenic pre-induction

机译:与骨髓相比,来自脂肪组织的间充质基质细胞的异位异位骨形成:通过软骨诱导预诱导

获取原文
获取原文并翻译 | 示例

摘要

Human mesenchymal stromal cells derived from bone marrow (BMSC) and adipose tissue (ATSC) represent a valuable source of progenitor cells for cell therapy and tissue engineering. While ectopic bone formation is a standard activity of human BMSC on calcium phosphate ceramics, the bone formation capacity of human ATSC has so far been unclear. The objectives of this study were to assess the therapeutic potency of ATSC for bone formation in an ectopic mouse model and determine molecular differences by standardized comparison with BMSC. Although ATSC contained less CD146~+ cells, exhibited better proliferation and displayed similar alkaline phosphatase activity upon osteogenic in vitro differentiation, cells did not develop into bone-depositing osteoblasts on β-TCP after 8weeks in vivo. Additionally, ATSC expressed less BMP-2, BMP-4, VEGF, angiopoietin and IL-6 and more adiponectin mRNA, altogether suggesting insufficient osteochondral commitment and reduced proangiogenic activity. Chondrogenic pre-induction of ATSC/β-TCP constructs with TGF-β and BMP-6 initiated ectopic bone formation in >75% of samples. Both chondrogenic pre-induction and the osteoconductive microenvironment of β-TCP were necessary for ectopic bone formation by ATSC pointing towards a need for inductive conditions/biomaterials to make this more easily accessible cell source attractive for future applications in bone regeneration.
机译:源自骨髓(BMSC)和脂肪组织(ATSC)的人间充质基质细胞代表了用于细胞治疗和组织工程的祖细胞的宝贵来源。虽然异位骨形成是人类BMSC在磷酸钙陶瓷上的标准活性,但迄今为止,人类ATSC的骨形成能力尚不清楚。这项研究的目的是评估异位小鼠模型中ATSC对骨形成的治疗效力,并通过与BMSC的标准化比较确定分子差异。尽管ATSC含有较少的CD146〜+细胞,在成骨体外分化后表现出更好的增殖并显示出相似的碱性磷酸酶活性,但在体内8周后,细胞并未在β-TCP上发育为成骨的成骨细胞。此外,ATSC表达较少的BMP-2,BMP-4,VEGF,血管生成素和IL-6,而脂联素mRNA则较多,这表明骨软骨的作用不足且促血管生成活性降低。用TGF-β和BMP-6对ATSC /β-TCP构建体进行软骨生成预诱导,可在超过75%的样本中引发异位骨形成。软骨形成的预诱导和β-TCP的骨传导性微环境对于ATSC异位骨形成都是必需的,这表明需要诱导条件/生物材料,以使其更容易获得,从而对将来在骨再生中的应用有吸引力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号